vs
GEヘルスケア(GEHC)とPILGRIMS PRIDE CORP(PPC)の財務データ比較。上の社名をクリックして会社を切り替えられます
GEヘルスケアの直近四半期売上が大きい($5.7B vs $4.5B、PILGRIMS PRIDE CORPの約1.3倍)。GEヘルスケアの純利益率が高く(10.3% vs 1.9%、差は8.4%)。GEヘルスケアの前年同期比売上増加率が高い(7.1% vs 3.3%)。過去8四半期でGEヘルスケアの売上複合成長率が高い(10.7% vs 1.8%)
GEヘルスケアは米国イリノイ州シカゴに本社を置く医療テクノロジー企業で、4つの事業部門を運営している。分子イメージング・CT・MRI・女性健診・X線システムを含む医用画像、超音波、遠隔患者モニタリング・麻酔呼吸ケア・循環器診断・乳幼児ケアを手がける患者ケアソリューション、医薬品診断の4部門で構成される。
ピルグリムズ・プライド社は米国の多国籍食品企業で、米国及びプエルトリコ最大級の鶏肉生産者であり、メキシコで第2位の鶏肉生産規模を誇る。2009年12月に破産手続きを完了し、2011年に米国本社をコロラド州グリーリーに移転、JBS S.A.が過半数の株式を保有している。2016年11月末に3億5000万ドルでGold'n Plumpを買収した。
GEHC vs PPC — 直接比較
損益計算書 — Q4 FY2025 vs Q4 FY2025
| 指標 | ||
|---|---|---|
| 売上 | $5.7B | $4.5B |
| 純利益 | $588.0M | $88.0M |
| 粗利率 | 39.7% | 9.5% |
| 営業利益率 | 14.5% | 4.5% |
| 純利益率 | 10.3% | 1.9% |
| 売上前年比 | 7.1% | 3.3% |
| 純利益前年比 | -18.4% | -62.7% |
| EPS(希薄化後) | $1.28 | $0.37 |
緑 = その指標でリード。会計年度がずれている場合は期間が異なる場合あり
8四半期 売上・利益トレンド
並べて比較する四半期履歴。決算期がずれていても暦四半期で整列
| Q4 25 | $5.7B | $4.5B | ||
| Q3 25 | $5.1B | $4.8B | ||
| Q2 25 | $5.0B | $4.8B | ||
| Q1 25 | $4.8B | $4.5B | ||
| Q4 24 | $5.3B | $4.4B | ||
| Q3 24 | $4.9B | $4.6B | ||
| Q2 24 | $4.8B | $4.6B | ||
| Q1 24 | $4.7B | $4.4B |
| Q4 25 | $588.0M | $88.0M | ||
| Q3 25 | $446.0M | $342.8M | ||
| Q2 25 | $486.0M | $355.5M | ||
| Q1 25 | $564.0M | $296.0M | ||
| Q4 24 | $721.0M | $235.9M | ||
| Q3 24 | $470.0M | $349.9M | ||
| Q2 24 | $428.0M | $326.3M | ||
| Q1 24 | $374.0M | $174.4M |
| Q4 25 | 39.7% | 9.5% | ||
| Q3 25 | 38.7% | 13.9% | ||
| Q2 25 | 39.6% | 15.0% | ||
| Q1 25 | 42.1% | 12.4% | ||
| Q4 24 | 42.8% | 12.7% | ||
| Q3 24 | 41.7% | 14.9% | ||
| Q2 24 | 41.4% | 15.2% | ||
| Q1 24 | 40.9% | 8.8% |
| Q4 25 | 14.5% | 4.5% | ||
| Q3 25 | 12.7% | 10.4% | ||
| Q2 25 | 13.1% | 10.8% | ||
| Q1 25 | 13.2% | 9.1% | ||
| Q4 24 | 15.1% | 7.0% | ||
| Q3 24 | 13.9% | 11.1% | ||
| Q2 24 | 12.6% | 9.7% | ||
| Q1 24 | 11.6% | 5.7% |
| Q4 25 | 10.3% | 1.9% | ||
| Q3 25 | 8.7% | 7.2% | ||
| Q2 25 | 9.7% | 7.5% | ||
| Q1 25 | 11.8% | 6.6% | ||
| Q4 24 | 13.6% | 5.4% | ||
| Q3 24 | 9.7% | 7.6% | ||
| Q2 24 | 8.8% | 7.2% | ||
| Q1 24 | 8.0% | 4.0% |
| Q4 25 | $1.28 | $0.37 | ||
| Q3 25 | $0.98 | $1.44 | ||
| Q2 25 | $1.06 | $1.49 | ||
| Q1 25 | $1.23 | $1.24 | ||
| Q4 24 | $1.58 | $1.00 | ||
| Q3 24 | $1.02 | $1.47 | ||
| Q2 24 | $0.93 | $1.37 | ||
| Q1 24 | $0.81 | $0.73 |
貸借対照表と財務力
直近四半期の流動性・レバレッジ・純資産のスナップショット
| 指標 | ||
|---|---|---|
| 現金・短期投資手元流動性 | $4.5B | $640.2M |
| 総負債低いほど良い | $10.0B | $3.1B |
| 株主資本純資産 | $10.4B | $3.7B |
| 総資産 | $36.9B | $10.3B |
| 負債/資本比率低いほどレバレッジが低い | 0.96× | 0.84× |
8四半期トレンド — 暦四半期で整列
| Q4 25 | $4.5B | $640.2M | ||
| Q3 25 | $4.0B | $612.6M | ||
| Q2 25 | $3.7B | $849.0M | ||
| Q1 25 | $2.5B | $2.1B | ||
| Q4 24 | $2.9B | $2.0B | ||
| Q3 24 | $3.5B | $1.9B | ||
| Q2 24 | $2.0B | $1.3B | ||
| Q1 24 | $2.6B | $870.8M |
| Q4 25 | $10.0B | $3.1B | ||
| Q3 25 | $10.3B | $3.1B | ||
| Q2 25 | $10.3B | $3.1B | ||
| Q1 25 | $8.8B | $3.2B | ||
| Q4 24 | $9.0B | $3.2B | ||
| Q3 24 | $10.3B | $3.2B | ||
| Q2 24 | $9.2B | $3.2B | ||
| Q1 24 | $9.3B | $3.3B |
| Q4 25 | $10.4B | $3.7B | ||
| Q3 25 | $10.0B | $3.5B | ||
| Q2 25 | $9.7B | $3.7B | ||
| Q1 25 | $9.2B | $3.1B | ||
| Q4 24 | $8.4B | $4.2B | ||
| Q3 24 | $8.3B | $4.2B | ||
| Q2 24 | $7.8B | $3.7B | ||
| Q1 24 | $7.4B | $3.5B |
| Q4 25 | $36.9B | $10.3B | ||
| Q3 25 | $36.1B | $10.0B | ||
| Q2 25 | $35.5B | $10.1B | ||
| Q1 25 | $33.6B | $11.0B | ||
| Q4 24 | $33.1B | $10.7B | ||
| Q3 24 | $33.9B | $10.7B | ||
| Q2 24 | $31.9B | $10.1B | ||
| Q1 24 | $32.2B | $9.8B |
| Q4 25 | 0.96× | 0.84× | ||
| Q3 25 | 1.03× | 0.87× | ||
| Q2 25 | 1.06× | 0.83× | ||
| Q1 25 | 0.95× | 1.02× | ||
| Q4 24 | 1.06× | 0.76× | ||
| Q3 24 | 1.24× | 0.76× | ||
| Q2 24 | 1.18× | 0.85× | ||
| Q1 24 | 1.25× | 0.96× |
キャッシュフローと資本効率
再投資後に実際に生み出すキャッシュ。純利益より操作が難しい
| 指標 | ||
|---|---|---|
| 営業キャッシュフロー直近四半期 | — | $291.2M |
| フリーキャッシュフロー営業CF - 設備投資 | — | $10.0M |
| FCFマージンFCF / 売上 | — | 0.2% |
| 設備投資強度設備投資 / 売上 | 2.4% | 6.2% |
| キャッシュ転換率営業CF / 純利益 | — | 3.31× |
| 直近12ヶ月FCF直近4四半期 | — | $653.1M |
8四半期トレンド — 暦四半期で整列
| Q4 25 | — | $291.2M | ||
| Q3 25 | — | $458.3M | ||
| Q2 25 | $94.0M | $495.2M | ||
| Q1 25 | $250.0M | $126.9M | ||
| Q4 24 | — | $349.3M | ||
| Q3 24 | — | $651.1M | ||
| Q2 24 | $-119.0M | $718.6M | ||
| Q1 24 | $419.0M | $271.0M |
| Q4 25 | — | $10.0M | ||
| Q3 25 | — | $275.9M | ||
| Q2 25 | $8.0M | $339.1M | ||
| Q1 25 | $98.0M | $28.1M | ||
| Q4 24 | — | $176.6M | ||
| Q3 24 | — | $565.3M | ||
| Q2 24 | $-183.0M | $617.7M | ||
| Q1 24 | $274.0M | $171.9M |
| Q4 25 | — | 0.2% | ||
| Q3 25 | — | 5.8% | ||
| Q2 25 | 0.2% | 7.1% | ||
| Q1 25 | 2.1% | 0.6% | ||
| Q4 24 | — | 4.0% | ||
| Q3 24 | — | 12.3% | ||
| Q2 24 | -3.8% | 13.5% | ||
| Q1 24 | 5.9% | 3.9% |
| Q4 25 | 2.4% | 6.2% | ||
| Q3 25 | 2.1% | 3.8% | ||
| Q2 25 | 1.7% | 3.3% | ||
| Q1 25 | 3.2% | 2.2% | ||
| Q4 24 | 1.9% | 4.0% | ||
| Q3 24 | 1.9% | 1.9% | ||
| Q2 24 | 1.3% | 2.2% | ||
| Q1 24 | 3.1% | 2.3% |
| Q4 25 | — | 3.31× | ||
| Q3 25 | — | 1.34× | ||
| Q2 25 | 0.19× | 1.39× | ||
| Q1 25 | 0.44× | 0.43× | ||
| Q4 24 | — | 1.48× | ||
| Q3 24 | — | 1.86× | ||
| Q2 24 | -0.28× | 2.20× | ||
| Q1 24 | 1.12× | 1.55× |
財務フロー比較
売上 → 粗利 → 営業利益 → 純利益のサンキー図
セグメント別売上内訳
GEHC
| Imaging Segment | $2.6B | 45% |
| PCS Segment | $824.0M | 14% |
| P Dx Segment | $790.0M | 14% |
| Specialized Ultrasound Subsegment | $735.0M | 13% |
| Monitoring Solutions Subsegment | $578.0M | 10% |
| Life Support Solutions Subsegment | $247.0M | 4% |
PPC
| Retail | $1.5B | 33% |
| Europe Reportable Segment | $1.4B | 31% |
| Food Service | $889.2M | 20% |
| Prepared Product | $332.8M | 7% |
| Product Export | $122.7M | 3% |
| Other Sales Channel | $96.0M | 2% |
| Other Product And Service | $79.7M | 2% |
| Related Party | $21.7M | 0% |
| Seara Meats B.V. | $18.9M | 0% |
| Penasul UKLTD | $10.3M | 0% |
| JBSUSA Food Company | $5.4M | 0% |